The over the counter amino acid L-Lysine has now been shown in the small group reported here to be an extremely effective prophylaxis regimen against SARS-CoV-2.
Alex Chaihorsky (Bio-Virus Research, Inc.), 2020
Amino Acid L-Lysine SARS-CoV-2 (COVID-19) Prophylaxis The over the counter amino acid L-Lysine has now been shown in the small group reported here to be an extremely effective prophylaxis regimen against SARS-Co-V-2. The first report of the therapeutic effect of L-Lysine on SARS-CoV-2 by the Bio-Virus Research team was published in ResearchGate this year. (1)This second report addresses its prophylactic use. 30 medical professionals at Salud Publica (public health) Department in Santiago, Dominican Republic, following the suggestion and advice of a member of the Bio-Virus team, self-administered the L-Lysine treatment protocol referenced above (1) of 2 gms per day of lysine with the required dietary restrictions. The study was conducted by the director of the district after she reviewed the data of the anti-viral properties of lysine, performed her own due diligence, and decided to try it in their sector. Less than 24 hours after first distributing L-Lysine to the first 18 patients, positive results gave the director the confidence to present this information to all sector employees as a prophylaxis regimen. After three months, through the spring to summer peak of COVID-19 cases in the Dominican Republic, with daily face-to-face exposure to SARS-CoV-2 patients, not a single doctor, nurse, or staff member fell ill or tested positive. They were tested once weekly with the current rapid test. In the months prior to L-Lysine prophylaxis, an average of two employees fell ill per month, and a comparison of similar sized public health departments had reported their staff routinely falling ill during the same period. Several other individual cases, with confirmed positive exposure living in close quarters and with no isolation possible proved lysine to be an excellent prophylaxis, or post exposure treatment if taken within 24 hours of exposure. The few failures reported were underdosed for weight or did not follow the essential dietary restrictions. A detailed explanation of the protocols, dietary restrictions, and cautions are given in the initial paper. Lysine, for example, should not be used by those with HIV, and used only with proper monitoring by those with autoimmune diseases, pacemakers or high calcium levels. Our results strongly suggest that frontline healthcare workers would find a new level of protection by using L-Lysine prophylactically. More extensive studies are required to confirm these findings and establish proper dosage protocols. CLICK HERE for more information.
CLICK HERE for information on some good stuff from Amazon.
CLICK HERE for information on a product from our Marketplace.